Patents by Inventor Hikaru Nagaoka

Hikaru Nagaoka has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-MALARIA PARASITE ANTIBODY
    Publication number: 20230322910
    Abstract: The present disclosure includes a monoclonal antibody or antibody fragment that binds to an epitope consisting of 5 to 20 consecutive amino acids in the amino acid sequence of SEQ ID NO: 1, and a method of detecting or quantifying an Ripr-derived malaria vaccine antigen comprising contacting a sample with the monoclonal antibody or antibody fragment.
    Type: Application
    Filed: August 25, 2021
    Publication date: October 12, 2023
    Inventors: Takafumi Tsuboi, Eizo Takashima, Hikaru Nagaoka, Akihisa Fukushima
  • Malaria vaccine
    Patent number: 11273212
    Abstract: The present invention relates to a polypeptide consisting of an amino acid sequence selected from: (a) the amino acid sequence of SEQ ID NO: 4 or SEQ ID NO: 8, (b) an amino acid sequence that differs from the amino acid sequence of SEQ ID NO: 4 or SEQ ID NO: 8 by substitution, deletion, addition, or insertion of 1 to 10, preferably 1-5, more preferably 1, 2 or 3 amino acids, and (c) an amino acid sequence that has at least 95%, preferably 97%, more preferably 99% sequence identity with the amino acid sequence of SEQ ID NO: 4 or SEQ ID NO: 8, and a malaria vaccine comprising the polypeptide, for example.
    Type: Grant
    Filed: November 10, 2017
    Date of Patent: March 15, 2022
    Assignees: Sumitomo Dainippon Pharma Co., Ltd., National University Corporation Ehime University
    Inventors: Akihisa Fukushima, Takafumi Tsuboi, Eizo Takashima, Hikaru Nagaoka
  • MALARIA VACCINE
    Publication number: 20190343943
    Abstract: The present invention relates to a polypeptide consisting of an amino acid sequence selected from: (a) the amino acid sequence of SEQ ID NO: 4 or SEQ ID NO: 8, (b) an amino acid sequence that differs from the amino acid sequence of SEQ ID NO: 4 or SEQ ID NO: 8 by substitution, deletion, addition, or insertion of 1 to 10, preferably 1-5, more preferably 1, 2 or 3 amino acids, and (c) an amino acid sequence that has at least 95%, preferably 97%, more preferably 99% sequence identity with the amino acid sequence of SEQ ID NO: 4 or SEQ ID NO: 8, and a malaria vaccine comprising the polypeptide, for example.
    Type: Application
    Filed: November 10, 2017
    Publication date: November 14, 2019
    Inventors: Akihisa Fukushima, Takafumi Tsuboi, Eizo Takashima, Hikaru Nagaoka